Want to join the conversation?
$CAH 4Q15 Call: We closed the acquisition of Harvard Drug in early July and this will further fuel our growth in generics. Specialty business continues its strong growth and we expect specialty business have made some important moves in the last 18-24 months.
$AAL is getting stronger into Dec. after a strong Nov..!! I’m feeling confident about their 4Q revenue forecast for a margin rise.
$KO’s CEO Muhtar Kent to step down next year. COO James Quincey will take the helm in what is already a smooth sailing scenario. And as always, shares reflect by growing 2% after the market opened.